Why Blood Pressure Control Matters in Pregnancy
Hypertension affects 10–15% of pregnancies and is a leading cause of maternal and fetal morbidity and mortality. Uncontrolled hypertension during pregnancy increases the risk of preeclampsia, placental abruption, preterm birth, intrauterine growth restriction, and maternal stroke. Appropriate treatment is essential — but many commonly used antihypertensives are contraindicated in pregnancy.
Medications to Avoid in Pregnancy
| Drug Class | Examples | Risk |
|---|---|---|
| ACE inhibitors | Lisinopril, enalapril, ramipril | Fetal renal tubular dysplasia, oligohydramnios, neonatal renal failure, skull hypoplasia — CONTRAINDICATED in 2nd and 3rd trimesters |
| ARBs | Losartan, valsartan, olmesartan | Same fetal toxicity as ACE inhibitors — CONTRAINDICATED in 2nd and 3rd trimesters |
| Direct renin inhibitors | Aliskiren | Same fetal toxicity — CONTRAINDICATED |
| Atenolol | Tenormin | Associated with fetal growth restriction; avoid if possible |
| Spironolactone | Aldactone | Anti-androgenic effects; avoid in pregnancy |
Safe Blood Pressure Medications in Pregnancy
| Medication | Drug Class | Safety Profile | Typical Dose |
|---|---|---|---|
| Labetalol | Alpha+beta blocker | Extensive safety data; first-line for acute severe hypertension in pregnancy | 200–800 mg/day PO; 20–80 mg IV bolus for acute |
| Nifedipine (extended-release) | Calcium channel blocker | Well-studied; first-line for chronic hypertension in pregnancy | 30–120 mg/day |
| Methyldopa | Central alpha-2 agonist | Longest safety record in pregnancy; first-line per many guidelines | 250–1,000 mg 2–3 times daily |
| Hydralazine | Direct vasodilator | Used for acute severe hypertension in pregnancy; IV formulation available | 5–10 mg IV every 20 minutes for acute |
| Metoprolol succinate | Beta-1 selective blocker | Generally considered safe; less data than labetalol | 25–200 mg/day |
| Amlodipine | Calcium channel blocker | Limited data but generally considered acceptable | 5–10 mg/day |
Treatment Thresholds
Current guidelines (ACOG 2019, ESC 2018) recommend:
- Severe hypertension (systolic ≥160 or diastolic ≥110 mmHg) — Treat immediately to reduce risk of maternal stroke; target <160/110 mmHg
- Non-severe hypertension (systolic 140–159 or diastolic 90–109 mmHg) — Treatment is recommended to reduce risk of severe hypertension; target 130–150/80–100 mmHg
Postpartum Considerations
After delivery, ACE inhibitors and ARBs can be restarted if needed. Labetalol, nifedipine, and methyldopa are compatible with breastfeeding. Atenolol should be avoided in breastfeeding mothers as it concentrates in breast milk.
References
- ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstet Gynecol. 2019;133(1):e26-e50.
- Regitz-Zagrosek V, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165-3241.
Save up to 80% on this medication
Use a free RxGo discount card at 67,000+ pharmacies — no sign-up, no insurance needed.
About the Author
James Okafor, RPh, MBA
Registered Pharmacist & Health Economics Writer
James Okafor is a registered pharmacist with over 12 years of experience in retail and clinical pharmacy settings. He holds an MBA with a focus on healthcare management and specializes in translating complex drug pricing, formulary, and insurance coverage topics into clear, actionable guidance for patients. Before joining RxGuide, James worked as a clinical pharmacist at a regional hospital system and as a pharmacy benefits consultant for a national PBM. His writing focuses on cost transparency, generic alternatives, and helping patients navigate the U.S. prescription drug system.
View full profile on our Editorial Team page →Get the RxGo app — free prescription discounts on the go
Works at 67,000+ pharmacies · No membership needed